ARS Pharmaceuticals (SPRY) Inventory Average (2024 - 2026)

ARS Pharmaceuticals has reported Inventory Average for 3 years, with the latest figure at $8.6 million in Q1 2026.

• Quarterly Inventory Average rose 37.69% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 37.69% YoY) and the FY2025 annual result came in at $6.8 million, changed N/A from the prior year.
• Inventory Average grew to $8.6 million in Q1 2026 per SPRY's latest filing, from $8.1 million in the prior quarter.
• Over five years, Inventory Average peaked at $8.6 million in Q1 2026 and troughed at $3.0 million in Q4 2024.
• A 3-year average of $7.0 million and a median of $8.0 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2025 and 2026: Inventory Average surged 172.5% in 2025, then surged 37.69% in 2026.
• Over 3 years, Inventory Average stood at $3.0 million in 2024, then surged by 172.5% to $8.1 million in 2025, then increased by 6.41% to $8.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $8.6 million, $8.1 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.